Real-time enrollment status for this systemic lupus erythematosus clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 2:55 AM UTC
| NCT Number | NCT06133972 |
| Recruiting Status | Recruiting |
| Condition | Systemic Lupus Erythematosus |
| Phase | PHASE3 |
| Target Enrollment | 550 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 8, 2026 (Jul 8, 2026) |
As of August 31, 2026: Clinical trial NCT06133972 is currently recruiting participants. This phase3 study for systemic lupus erythematosus is actively seeking new participants at 22 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06133972 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06133972 was last updated Jul 8, 2026 (July 8, 2026). HelloStudys verifies this status automatically.